(Q35142061)

6 August 2017

1 reference

title

Predictors of response in depression (English)

1 reference

6 August 2017

Karin Esposito

1

1 reference

PubMed ID

12778838

6 August 2017

Paul Goodnick

series ordinal

2

1 reference

6 August 2017

1 June 2003

1 reference

Psychiatric Clinics of North America

6 August 2017

1 reference

6 August 2017

26

1 reference

6 August 2017

2

1 reference

6 August 2017

353-365

1 reference

The NIMH Depression Awareness, Recognition, and Treatment Program: structure, aims, and scientific basis

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

Bupropion and Fluoxetine in Depressive Subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

Bupropion slow-release response in depression: diagnosis and biochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

Toward a rational pharmacotherapy of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

Assessing the comparative effectiveness of antidepressant therapies: a prospective clinical practice study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

Predictors of an acute antidepressant response to fluoxetine and sertraline

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

Predictors of response to lithium augmentation in tricyclic antidepressant-resistant depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

Five-year outcome for maintenance therapies in recurrent depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

Depressive breakthrough.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

Prediction of tricyclic antidepressant response: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

Predictors of drug response in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

Endogenomorphic depression. A conceptual and terminological revision

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

Severity of depression and response to fluoxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

Forms of atypical depression and their response to antidepressant drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

No gender differences in placebo responses of patients with major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

Outcome of hospital-treated depression at 4.5 years. An elderly and a younger adult cohort compared

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

Family history as a predictor of poor long-term outcome in depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

Influence of socio-economic deprivation on the prevalence and outcome of depression in primary care: the Hampshire Depression Project

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

Reduced REM latency predicts response to tricyclic medication in depressed outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

Post-seizure EEG fractal dimension of first ECT predicts antidepressant response at two weeks.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

Sleep deprivation as a predictor of response to light therapy in major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

The DST as a predictor of outcome in depression: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

Basal plasma dehydroepiandrosterone sulfate level: a possible predictor for response to electroconvulsive therapy in depressed psychotic inpatients.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

Plasma serotonin level after 1 day of fluoxetine treatment: a biological predictor for antidepressant response?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

Tryptophan depletion and risk of depression relapse: a prospective study of tryptophan depletion as a potential predictor of depressive episodes

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

Imipramine binding as a predictor of fluoxetine response in depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

Neurochemistry and paroxetine response in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

Plasma ratio tryptophan/neutral amino acids in relation to clinical response to paroxetine and clomipramine in patients with major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

Temperament and character inventory dimensions as a predictor of response to antidepressant treatment in major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

Serotonergic autoreceptor blockade in the reduction of antidepressant latency: personality variables and response to paroxetine and pindolol.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

Perceived parenting pattern and response to antidepressants in patients with major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

Cingulate function in depression: a potential predictor of treatment response.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2802%2900104-1

7 January 2021

10.1016/S0193-953X(02)00104-1

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12778838